Pfizer Targets Up to $64B Revenue in 2025 Amid Strategic Cost Savings
Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our website policy prior to making financial decisions. Pfizer has reaffirmed its guidance for the full year 2024 and provided new projections for 2025. The pharmaceutical giant has set its revenue expectations for 2025 between $61.0 billion and $64.0 billion, with adjusted…